as 11-14-2024 12:34pm EST
Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.
Founded: | 2001 | Country: | United States |
Employees: | N/A | City: | SMYRNA |
Market Cap: | 17.1M | IPO Year: | N/A |
Target Price: | $14.20 | AVG Volume (30 days): | 3.6M |
Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | -7.44 | EPS Growth: | N/A |
52 Week Low/High: | $1.09 - $11.18 | Next Earning Date: | 11-12-2024 |
Revenue: | $3,090,161 | Revenue Growth: | N/A |
Revenue Growth (this year): | N/A | Revenue Growth (next year): | 565.58% |
GOVX Breaking Stock News: Dive into GOVX Ticker-Specific Updates for Smart Investing
GuruFocus.com
2 days ago
GlobeNewswire
3 days ago
TipRanks
3 days ago
GlobeNewswire
10 days ago
GuruFocus.com
a month ago
GlobeNewswire
a month ago
GlobeNewswire
2 months ago
Insider Monkey
2 months ago
The information presented on this page, "GOVX GeoVax Labs Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.